ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 241 filers reported holding ALKERMES PLC in Q1 2016. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326 | -56.6% | 11,631 | -51.6% | 0.03% | -43.9% |
| Q2 2023 | $752 | -99.8% | 24,011 | +26.0% | 0.06% | +54.1% |
| Q1 2022 | $501,000 | +130.9% | 19,051 | +64.3% | 0.04% | +146.7% |
| Q1 2021 | $217,000 | -61.1% | 11,594 | -58.6% | 0.02% | -75.0% |
| Q4 2020 | $558,000 | +134.5% | 27,981 | +95.1% | 0.06% | +46.3% |
| Q3 2020 | $238,000 | +13.3% | 14,339 | +32.9% | 0.04% | +156.2% |
| Q3 2019 | $210,000 | -45.2% | 10,789 | +2.8% | 0.02% | -27.3% |
| Q1 2019 | $383,000 | -12.8% | 10,498 | -29.5% | 0.02% | -8.3% |
| Q4 2018 | $439,000 | +85.2% | 14,891 | +167.1% | 0.02% | +60.0% |
| Q3 2018 | $237,000 | -65.4% | 5,576 | -52.7% | 0.02% | -59.5% |
| Q1 2018 | $684,000 | +240.3% | 11,794 | +198.4% | 0.04% | +270.0% |
| Q3 2017 | $201,000 | -22.1% | 3,953 | +21.5% | 0.01% | -73.0% |
| Q4 2015 | $258,000 | -43.2% | 3,254 | -53.9% | 0.04% | -9.8% |
| Q2 2015 | $454,000 | – | 7,053 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |